DEA Says Hemp Company Cannot Challenge Its Federal-Ban Position on HHC

The U.S. Drug Enforcement Administration says a hemp company lacks standing to challenge the agency’s position that HHC, a synthetic cannabinoid, is federally prohibited. The filing responds to litigation brought by the hemp sector and keeps the legal dispute over the federal status of synthetic and semi-synthetic cannabinoids in focus.

For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.